SCHEMBL3377632

SCHEMBL3377632

CSCC(C)(C)NC(=O)c1c(OS(=O)(=O)C(F)(F)F)cccc1C(=O)O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
DRD2 P14416 7/20 0.35
DRD3 P35462 5/20 0.35
HTR1D P28221 2/20 0.35
ALOX15 P16050 1/20 0.34
DRD4 P21917 3/20 0.33
HTR5A P47898 1/20 0.33
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
MAPT P10636 1/20 0.32
CYP2C19 P33261 1/20 0.32
RXFP1 Q9HBX9 2/20 0.32
DRD1 P21728 1/20 0.31
DRD5 P21918 1/20 0.31
CA12 O43570 1/20 0.31
CA9 Q16790 1/20 0.31
KDM4E B2RXH2 1/20 0.31
HPGD P15428 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3377641 0.91 NPSR1 (0.40) NPSR1L3MBTL1DRD2DRD3HTR1D
SCHEMBL2891984 0.89 NPSR1 (0.39) NPSR1L3MBTL1ALOX15CA12CA9
SCHEMBL3373569 0.88 NPSR1 (0.40) NPSR1L3MBTL1ALOX15CYP1A2CYP3A4
SCHEMBL3377816 0.85 KMT2A (0.39) NPSR1L3MBTL1DRD2DRD3HTR1D
SCHEMBL3374780 0.81 POLB (0.39) L3MBTL1DRD2DRD3HTR1DDRD4
SCHEMBL3377672 0.80 DRD2 (0.35) NPSR1DRD2DRD3HTR1DDRD4
SCHEMBL2891988 0.80 NPSR1 (0.41) NPSR1L3MBTL1ALOX15MAPTCA12
SCHEMBL3373572 0.79 NPSR1 (0.43) NPSR1L3MBTL1ALOX15MAPTCA12
SCHEMBL550487 0.79 ALB (0.40) NPSR1L3MBTL1ALOX15MAPT
SCHEMBL3379105 0.78 NPSR1 (0.40) NPSR1L3MBTL1DRD2DRD3HTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1517886-B1 NOVEL PHTHALAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2010-11-10 EP disclosed
US-7132455-B2 Phthalamide derivatives BAYER CROPSCIENCE AG (DE) 2006-11-07 US disclosed
US-20060035967-A1 Novel phthalamide derivatives BAYER INTELLECTUAL PROPERTY GMBH (DE) 2006-02-16 US disclosed
EP-1517886-A1 NOVEL PHTHALAMIDE DERIVATIVES Bayer CropScience AG (DE) 2005-03-30 EP disclosed
WO-2004000796-A1 NOVEL PHTHALAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2003-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060035967-A1 Novel phthalamide derivatives HDAC1, HDAC2, CRY1 NPSR1 918/4885L3MBTL1 1720/4885DRD2 2764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.